FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill

04 Nov 2016

• By Lauren Nardella

The Cosmetic Modernization Amendments of 2015 is touted by small business as a more appropriately sized update to the regulatory framework than the front-running PCPSA. However, some provisions seen as vital are absent from the bill, while its call for FDA to accept CIR safety decisions could be deemed unconstitutional, an FDA official suggests in a letter to Senate HELP Committee Chair Lamar Alexander.

If lawmakers and industry stakeholders knuckle down in the next Congress to reach a compromise on cosmetics reform legislation, FDA’s recent exchanges with prominent Senators likely will serve as a compass to help guide discussions.

The agency offered perspective in an Oct. 17 letter to Sen. Lamar Alexander, R-Tenn., that may give small business food...